HRP20040508A2 - 1,3-diarylprop-2-en-1-ones, compositions containing the same and use thereof - Google Patents

1,3-diarylprop-2-en-1-ones, compositions containing the same and use thereof Download PDF

Info

Publication number
HRP20040508A2
HRP20040508A2 HR20040508A HRP20040508A HRP20040508A2 HR P20040508 A2 HRP20040508 A2 HR P20040508A2 HR 20040508 A HR20040508 A HR 20040508A HR P20040508 A HRP20040508 A HR P20040508A HR P20040508 A2 HRP20040508 A2 HR P20040508A2
Authority
HR
Croatia
Prior art keywords
propenone
amino
methoxy
methyl
trimethoxyphenyl
Prior art date
Application number
HR20040508A
Other languages
English (en)
Croatian (hr)
Inventor
Mailliet Patrick
Combeau C�cile
Bissery Marie-Christine
Cherrier Marie-Pierre
Caulfield Thomas
Tiraboschi Gilles
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0115739A external-priority patent/FR2833008B1/fr
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HRP20040508A2 publication Critical patent/HRP20040508A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32—N-nitroguanidines
    • C07C279/36—Substituted N-nitroguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
HR20040508A 2001-12-05 2004-06-04 1,3-diarylprop-2-en-1-ones, compositions containing the same and use thereof HRP20040508A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0115739A FR2833008B1 (fr) 2001-12-05 2001-12-05 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
FR0214217 2002-11-14
PCT/FR2002/004143 WO2003048106A2 (fr) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation

Publications (1)

Publication Number Publication Date
HRP20040508A2 true HRP20040508A2 (en) 2005-08-31

Family

ID=26213287

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040508A HRP20040508A2 (en) 2001-12-05 2004-06-04 1,3-diarylprop-2-en-1-ones, compositions containing the same and use thereof

Country Status (23)

Country Link
EP (1) EP1453790A2 (fr)
JP (1) JP2005531494A (fr)
KR (1) KR20050044712A (fr)
CN (1) CN1612856A (fr)
AR (1) AR037479A1 (fr)
AU (1) AU2002365644A1 (fr)
BR (1) BR0214694A (fr)
CA (1) CA2469193A1 (fr)
CO (1) CO5580759A2 (fr)
EA (1) EA006803B1 (fr)
HR (1) HRP20040508A2 (fr)
HU (1) HUP0500100A2 (fr)
IL (1) IL162223A0 (fr)
MA (1) MA27351A1 (fr)
MX (1) MXPA04005226A (fr)
NZ (1) NZ533224A (fr)
PA (1) PA8558501A1 (fr)
PE (1) PE20030758A1 (fr)
PL (1) PL370676A1 (fr)
RS (1) RS47804A (fr)
SV (1) SV2003001422A (fr)
TW (1) TW200300685A (fr)
WO (1) WO2003048106A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854399B1 (fr) * 2003-04-30 2006-11-17 Aventis Pharma Sa 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation
EP1598353A1 (fr) 2004-05-17 2005-11-23 Boehringer Ingelheim International GmbH Pyrrolobenzimidazolones et leur utilisation en tant qu'agents antiproliferatifs
WO2017103637A1 (fr) 2015-12-18 2017-06-22 Blirt S.A. Composés de diphénylpropane et leur activité cytotoxique
CN109467549B (zh) * 2018-12-07 2021-02-09 中国药科大学 喹啉取代查尔酮类化合物、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
JPH08277242A (ja) * 1995-02-08 1996-10-22 Kyowa Hakko Kogyo Co Ltd プロペノン誘導体
CN1172476A (zh) * 1995-12-01 1998-02-04 协和发酵工业株式会社 丙烯酮衍生物
EP0996432A2 (fr) * 1997-06-26 2000-05-03 Statens Seruminstitut 1,3-bis-aromatique-prop-2-en-1-ones, 1,3-bis-aromatique-propane-1-ones et 1,3-bis-aromatique-prop-2-yn-1-ones a action biologique

Also Published As

Publication number Publication date
MA27351A1 (fr) 2005-06-01
NZ533224A (en) 2006-03-31
IL162223A0 (en) 2005-11-20
HUP0500100A2 (hu) 2005-05-30
CN1612856A (zh) 2005-05-04
WO2003048106A3 (fr) 2004-03-25
MXPA04005226A (es) 2004-10-11
JP2005531494A (ja) 2005-10-20
PE20030758A1 (es) 2003-10-07
PA8558501A1 (es) 2003-09-05
EP1453790A2 (fr) 2004-09-08
WO2003048106A2 (fr) 2003-06-12
PL370676A1 (en) 2005-05-30
AR037479A1 (es) 2004-11-10
AU2002365644A1 (en) 2003-06-17
TW200300685A (en) 2003-06-16
EA006803B1 (ru) 2006-04-28
KR20050044712A (ko) 2005-05-12
CO5580759A2 (es) 2005-11-30
EA200400764A1 (ru) 2004-12-30
BR0214694A (pt) 2004-12-14
SV2003001422A (es) 2003-07-10
CA2469193A1 (fr) 2003-06-12
RS47804A (en) 2006-12-15

Similar Documents

Publication Publication Date Title
KR102642823B1 (ko) 모발 성장을 조절하기 위한 조성물 및 방법
JP5699152B2 (ja) リジン特異的デメチラーゼ−１阻害剤およびその使用
RU2544856C2 (ru) НОВЫЕ ПРОИЗВОДНЫЕ 2,3,4,5-ТЕТРАГИДРО-1-ПИРИДО[4,3-b]ИНДОЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
EP2456754B1 (fr) Derives d'acyl-guanidines modulateurs de la voie de signalisation des proteines hedgehog
JP2002515488A (ja) カルボキサミド化合物、組成物、及びｐａｒｐ活性の抑制方法
EP1773835B1 (fr) Derives de pyrido-pyrido-pyrimidine, leur preparation, leur application dans le traitement du cancer
AU2008288897A1 (en) Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity
JP5778145B2 (ja) 抗癌剤としてのベンゾキノリジニウム塩誘導体
EA019454B1 (ru) Замещенные пиразолы, композиции их содержащие, способ получения и применение
MX2007015274A (es) Derivados de indol que tienen actividad antitumoral.
HU219232B (en) Bis-naphthalimide derivatives, process for producing them, and pharmaceutical compositions containing them
US20050203170A1 (en) 1,3-Diarylprop-2-en-1-ones, compositions containing them and use thereof
HRP20040508A2 (en) 1,3-diarylprop-2-en-1-ones, compositions containing the same and use thereof
PT839137E (pt) Diamidas acidas aromaticas com accao antigastrina um metodo para a sua preparacao e para o seu uso farmaceutico
ES2272816T3 (es) Aril-cicloalcanos sustituidos y su utilizacion como agentes anticancerigenos.
KR20040108787A (ko) 중추 신경계 장애의 치료에 사용하기 위한 실질적으로순수한 고체 형태의 3-인돌릴피브르산의 에놀 토토머
US8404863B2 (en) Tetrahydroindoles having sphingosine-1-phosphate receptor activity
US20040229931A1 (en) 1-Aryl-3-(indol-5-yl) prop-2-en-1-ones, compositions containing them and use
KR101761682B1 (ko) 신규한 인돌-2-카르복실레이트 유도체 및 이를 유효성분으로 포함하는 약학적 조성물
RU2184122C2 (ru) Гликоконъюгаты 20(s)-камптотецина
KR100916716B1 (ko) 3-클로로-5-치환-퀴녹살린-2-아민 유도체 및 약제학적으로허용 가능한 그의 염, 그의 제조방법 및 그를 유효성분으로함유하는 ｓｐｃ 수용체 활성으로 유발되는 염증관련 질환치료제
JP2006525291A (ja) １−アリール−３−（インドール−５−イル）プロパ−２−エン−１−オン、該化合物を含む組成物、及びそれらの使用
RU2173316C2 (ru) Новые гетероциклические производные и их фармацевтическое использование
FR2833008A1 (fr) 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
JPS60214781A (ja) ピペラジン及びホモピペラジンの置換された１−（４−アミノ−６，７−ジアルコキシ−キナゾリニル）−４−シクロクロヘキセニル誘導体

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20051202

Year of fee payment: 4

ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
OBST Application withdrawn